← Evidence map

ArticleCancers2024

Abemaciclib for the Treatment of HR+HER2- Metastatic Breast Cancer: An Institutional Experience.

Erika Matos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2024
2025
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 38791907